Satsuma Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
4819 Emperor Boulevard, Suite 340, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:54 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report NONE Jun 13, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 10, 2023
SC 13G/A Report NONE Feb 8, 2023
SC 13G Report NONE Nov 16, 2022
SC 13G/A Report Nov 16, 2022
SC 13G/A Report Feb 25, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G Report Feb 14, 2022
SC 13G/A Report AMENDMENT TO FORM SC 13G Feb 11, 2022
SC 13G/A Report SC 13G/A Oct 19, 2021
SC 13G/A Report MS AMENDMENT Apr 9, 2021
SC 13G Report INITIAL FILING Mar 15, 2021
SC 13G/A Report SC 13G/A Feb 16, 2021
SC 13G/A Report MS AMENDMENT Feb 12, 2021
SC 13G Report MS INITIAL Dec 18, 2020
SC 13G/A Report SC 13G/A Dec 4, 2020
SC 13G/A Report SEC SCHEDULE 13G Oct 9, 2020
SC 13G/A Report SEC SCHEDULE 13G Aug 10, 2020
SC 13G/A Report SC 13G/A Feb 14, 2020
SC 13G/A Report Feb 14, 2020
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Feb 13, 2020
SC 13G/A Report SEC SCHEDULE 13G Jan 27, 2020
SC 13G Report SC 13G Nov 27, 2019
SC 13G Report Oct 21, 2019
SC 13G Report SEC SCHEDULE 13G Oct 10, 2019
SC 13G Report SCHEDULE 13G Sep 23, 2019